Results 151 to 160 of about 11,948 (164)

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Lancet Respiratory Medicine,the, 2021
Vincent C Marconi, Athimalaipet V Ramanan, Stephanie De Bono   +2 more
exaly  

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Lancet, The, 2023
exaly  

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact

Journal of Infection, 2020
Fabrizio Cantini, Laura Niccoli, Daniela Matarrese   +2 more
exaly  

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

Lancet, The, 2023
exaly  

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka   +2 more
exaly  

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Lancet, The, 2022
exaly  

Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19

Pharmacotherapy, 2020
Sarah C J Jorgensen, Lisa D Burry
exaly  

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment

Arthritis and Rheumatology, 2017
Roy M Fleischmann, César R Ramos-Remus, Stephanie De Bono   +2 more
exaly  

Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19

International Immunopharmacology, 2020
Zhigang Qi
exaly  

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Journal of the American Academy of Dermatology, 2019
Jonathan I Silverberg
exaly